Ark. judge fines Johnson & Johnson more than $1.1B in Risperdal case
April 11, 2012
CONTINUED...
practices act.
Jurors returned a quick verdict Tuesday in favor of the state, which had argued that Janssen Pharmaceuticals Inc. lied about the potentially life-threatening side effects of Risperdal. They deliberated for three hours, just as long as it took to make closing arguments.
The state's Medicaid-fraud law calls for a minimum fine of $5,000 per violation - or at least $1.2 billion for each of the 250,000 Risperdal prescriptions the state's Medicaid program paid for over 3 and a half years. Previous verdicts against J&J include a $327 million civil penalty in South Carolina that a judge upheld in
Visit other CBS Interactive sites:
© MMXII CBS Interactive Inc. All rights reserved.